Effect of bisphosphonates on orthodontic tooth movement-an update.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4437175)

Published in J Clin Diagn Res on April 01, 2015

Authors

Sindhuja Krishnan1, Saravana Pandian1, Aravind Kumar S2

Author Affiliations

1: Post Graduation, Department of Orthodontics and Dentofacial Orthopaedics, Saveetha Dental College, Saveetha, University , Chennai, Tamilnadu, India .
2: Professor, Department of Orthodontics and Dentofacial Orthopaedics, Saveetha Dental College, Saveetha, University , Chennai, Tamilnadu, India .

Articles cited by this

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg (2009) 8.79

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med (2006) 7.46

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg (2004) 6.38

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol (2005) 4.69

Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther (2001) 3.59

Cellular and molecular mechanisms of action of bisphosphonates. Cancer (2000) 3.57

Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc (2006) 3.41

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther (2002) 2.83

Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc (2008) 2.36

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res (2002) 1.97

The osteoporosis revolution. Ann Intern Med (1997) 1.57

Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother (2005) 1.33

Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone (2001) 1.32

The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum (2001) 1.31

The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res (1999) 1.30

Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones. Bone (1996) 1.26

Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci (2010) 1.21

Clinical development of anti-RANKL therapy. Arthritis Res Ther (2007) 1.17

Sutural development: structure and its response to rapid expansion. Am J Orthod (1977) 1.14

Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors. Bone (2002) 1.07

Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats. Am J Orthod Dentofacial Orthop (1994) 1.03

Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement. Bone (2007) 0.98

Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats. Eur J Orthod (2004) 0.96

Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movements in rats. J Dent Res (1994) 0.95

Orthodontic tooth movement and root resorption in ovariectomized rats treated by systemic administration of zoledronic acid. Am J Orthod Dentofacial Orthop (2012) 0.94

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head Face Med (2010) 0.94

The morphologic and biochemical effects of tensile force application to the interparietal suture of the Sprague-Dawley rat. Am J Orthod Dentofacial Orthop (1987) 0.93

[Bisphosphonate-associated osteonecrosis of the jaw]. Mund Kiefer Gesichtschir (2006) 0.92

Effects of bisphosphonate on the remodeling of rat sagittal suture after rapid expansion. Angle Orthod (2001) 0.91

Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats. J Dent Res (1996) 0.89

Bisphosphonate treatment: an orthodontic concern calling for a proactive approach. Am J Orthod Dentofacial Orthop (2007) 0.88

Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis. J Oral Maxillofac Surg (2006) 0.88

An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars. Am J Orthod Dentofacial Orthop (1999) 0.87

New bisphosphonates in the treatment of bone diseases. Drugs Aging (1999) 0.86

Inhibition of tooth movement by osteoprotegerin vs. pamidronate under conditions of constant orthodontic force. Eur J Oral Sci (2007) 0.86

Clodronate inhibits PGE(2) production in compressed periodontal ligament cells. J Dent Res (2006) 0.85

Treatment of osteoporosis with bisphosphonates. Endocrinol Metab Clin North Am (1998) 0.81

Orthodontically induced root resorption in rat molars after 1-hydroxyethylidene-1,1-bisphosphonate injection. Acta Odontol Scand (1996) 0.81

Rapid palatal expansion: Part 1. Mineralization pattern of the midpalatal suture in cats. Am J Orthod Dentofacial Orthop (1998) 0.81

Histomorphometric evaluation of the effects of zoledronic acid on mandibular distraction osteogenesis in rabbits. J Oral Maxillofac Surg (2008) 0.80

Orthodontic treatment of patients using bisphosphonates: a report of 2 cases. Am J Orthod Dentofacial Orthop (2007) 0.80

Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis. Am J Orthod Dentofacial Orthop (2009) 0.80

The role of bisphosphonates in multiple myeloma. Ann Intern Med (2000) 0.80

Effects of alendronate on rate of distraction in rabbit mandibles. J Oral Maxillofac Surg (2008) 0.79

Bisphosphonates as a risk factor for adverse orthodontic outcomes: a retrospective cohort study. Am J Orthod Dentofacial Orthop (2012) 0.79

Bisphosphonate administration alters subcellular localization of vacuolar-type H(+)-ATPase and cathepsin K in osteoclasts during experimental movement of rat molars. Anat Rec (2000) 0.79

The effect of long-term low-dose diphosphonate treatment on rat bone. Clin Orthop Relat Res (1982) 0.77